Pfizer, Allergan combine to create the world's largest drugmaker
UNDATED - Pfizer and Allergan will join in a $160 billion deal to create the world's largest drugmaker.
The transaction is valued at $363.63 per Allergan share. Allergan shareholders will receive 11.3 shares of the combined company for each of their shares. Pfizer stockholders get one share of the combined company for each of theirs.
It's the biggest health care deal ever and the largest so-called inversion in history, a tax-saving maneuver in which a U.S. company reorganizes in a country with a lower corporate tax rate. U.S. efforts to curb the practice have so far proven ineffectual.
Botox maker Allergan is based in Ireland but runs much of its operations out of New Jersey.
Pfizer and Allergan will be combined under Allergan PLC, which will be renamed Pfizer PLC.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Baton Rouge rapper NBA YoungBoy pleads not guilty to federal weapons charges
Officials with EBR Schools face pushback from community over 'Smart Start' plan
Thursday's 2 Your Health Report
Roofers slammed after hail storms damage properties in Ascension
Parish offers 'no comment' to eroding drainage ditch issue in Prairieville
'We have a plan': Coach O quiet on how Title IX scandal...
Southeastern regains sole possession of first place in Southland standings with win...
Max Johnson in the mix for LSU starting quarterback job
Coach O admits to mistakes, takes steps to correct them in the...
Saints QB Jameis Winston gets emotional discussing Drew Brees